MedTrace Logo

Episodic Acyclovir Therapy for Genital Ulcers

NCT00164424 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 613

Last updated 2012-09-11

No results posted yet for this study

Summary

The purpose of this study is to determine if acyclovir episodic treatment has an effect in ulcer healing and if it should be added to the syndromic management of genital ulcer disease.

Conditions

  • HIV Infections
  • Ulcer
  • Herpes Simplex

Interventions

DRUG

Acyclovir

Sponsors & Collaborators

Principal Investigators

  • Gabriela Paz Bailey, MD · Centers for Disease Control and Prevention

  • David Lewis, MD · STIRC, National Institute for Communicable Diseases (NICD), South Africa

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-03-31
Primary Completion
2009-03-31
Completion
2011-07-31

Countries

  • South Africa

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00164424 on ClinicalTrials.gov